Midgard Science

Labs / ADME, DMPK & toxicology

Araris Biotech

Wädenswil, Switzerland · ararisbiotech.com

Araris Biotech AG develops antibody-drug conjugate (ADC) linker technology and ADC candidates. It works on off-the-shelf antibody conjugation for cancer therapies and has programs including ARC-02 and ARC-401.

They take quote requests by email.

What they offer

  • ADC linker technology development

    Develops a proprietary peptide linker platform for site-specific payload attachment to antibodies in one step.

  • ADC candidate design

    Designs homogenous, stable, highly soluble ADCs using its linker technology.

  • One-step ADC conjugation

    Generates ADCs from off-the-shelf antibodies without re-engineering or reducing the antibody.

What they work on

Modalities
Antibody, ADC, Peptide
Therapeutic areas
cancer, lymphomas, solid tumors
Address
Riedhofstrasse 11 , CH-8804 , Au ZH , Switzerland How to get to us info

Similar labs. Aurigene Pharmaceutical Services, Glykos, Sai Life, Veloxity Labs

Found in a contract services directory. Listing built from ararisbiotech.com. Work here? Claim this listing.

Araris Biotech · Midgard Science